September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
A randomised controlled crossover trial of gabapentin and memantine in infantile nystagmus
Author Affiliations & Notes
  • Rebecca McLean
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Viral Sheth
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Ali Abbas
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Archana Pradeep
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Frank A Proudlock
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Irene Gottlob
    Ophthalmology, University of Leicester, Leicester, United Kingdom
  • Footnotes
    Commercial Relationships   Rebecca McLean, None; Viral Sheth, None; Ali Abbas, None; Archana Pradeep, None; Frank Proudlock, None; Irene Gottlob, None
  • Footnotes
    Support  Fight for Sight 1773
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Rebecca McLean, Viral Sheth, Ali Abbas, Archana Pradeep, Frank A Proudlock, Irene Gottlob; A randomised controlled crossover trial of gabapentin and memantine in infantile nystagmus. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : To investigate the effectiveness of gabapentin and memantine in infantile nystagmus (IN) on both visual function and eye movement

Methods : A randomised, triple masked, controlled crossover trial of gabapentin and memantine was performed on 66 participants with IN. Each treatment period was 17 weeks with a 6 week washout period before the next treatment was commenced. Outcome measures were 25% improvement in visual acuity (primary outcome), 25% improvement in eye movement (nystagmus intensity and expanded nystagmus acuity function [NAFX]), absolute change in visual function (visual acuity and reading parameters) and eye movement and descriptive analysis of nystagmus waveforms responding to treatment. Time course of treatment was also assessed to evaluate when the treatments were at their most effective and at what dosage this occurred.

Results : Gabapentin and memantine did not improve any visual function parameters as a 25% improvement or when assessing the absolute differences. In contrast null region nystagmus intensity (p=0.014) and NAFX (p=0.028) were significantly different for treatment as gabapentin reduced intensity and improved NAFX by 25%. For absolute differences in null region nystagmus intensity gabapentin was also significant (p=0.047). Pendular waveforms prevalently appeared in those participants responding to gabapentin. Treatment, in particular gabapentin, was most effective after initial administration and directly after an increase in the dosage. Baseline measurements were often a predictor for success of treatment; the worse the baseline the more likely treatment would be effective. Gabapentin and memantine were both reasonably well tolerated.

Conclusions : Gabapentin, and not memantine, significantly reduces eye movement in IN but does not improve visual function. Pendular waveforms appeared to be most sensitive to treatment. Reduction of pendular waveforms support previous studies in acquired pendular nystagmus and may suggest a specific underlying mechanism that is most sensitive to treatment.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×